Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Monte Rosa Therapeutics, Inc. | 600,004 | reported | 01 May 2026 | tx 15+3,012,740−26,534 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 01 May 2026 | SALE | Monte Rosa Therapeutics, Inc. | 5,467 | 18.92 USD | 10b5-1 |
| 02 Mar 2026 | SALE | Monte Rosa Therapeutics, Inc. | 5,466 | 17.92 USD | |
| 07 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 309 | 24.57 USD | |
| 07 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 1,450 | 23.88 USD | |
| 07 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 3,707 | 23.24 USD | |
| 05 Jan 2026 | SALE | Monte Rosa Therapeutics, Inc. | 10,135 | 15.17 USD | |
| 02 Jan 2026 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 90,000 | — | |
| 02 Jan 2026 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 406,000 | 0.00 USD | deriv |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 128,000 | — | |
| 02 Jan 2025 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 575,000 | 0.00 USD | deriv |
| 02 Jan 2024 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 346,000 | 0.00 USD | deriv |
| 03 Jan 2023 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 472,000 | 0.00 USD | deriv |
| 01 Mar 2022 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 315,600 | 0.00 USD | deriv |
| 12 Apr 2021 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 538,517 | 0.00 USD | deriv |
| 23 Jun 2021 | GRANT_AWARD | Monte Rosa Therapeutics, Inc. | 141,623 | 0.00 USD | deriv |